Here are 20 hypothetical URLs based on the provided base URLs, keywords, and date range:

1. https://investors.bettertx.com/news-events/press-releases/2025-05-15-danuglipron-phase-3-results
2. https://www.bms.com/media/press-releases/2025/05/20/bms-announces-partnership-for-semaglutide-distribution.html
3. https://www.bostonpharmaceuticals.com/news/2025-05-25-tirzepatide-approval
4. https://www.caliway.com.tw/en/news/2025-06-01-mazdutide-clinical-trial-update
5. https://www.cap-rx.com/press-releases/2025-05-10-wegovy-supply-chain-expansion
6. https://carmot.us/news/2025/05/cagrisema-phase-2-results-announced
7. https://www.cphi-online.com/news/all.html?keyword=PF-06882961&date=2025-05-01
8. https://www.chronwell.com/press/2025-05-30-rybelsus-real-world-data-analysis
9. https://www.cspc.com.hk/en/global/news.php?id=20250518&title=ibi-362-regulatory-submission
10. http://www.ddpharmatech.com/news/2025-05-12-ly3298176-manufacturing-partnership
11. https://investors.bettertx.com/news-events/press-releases/2025-05-22-cagrilintide-market-forecast
12. https://www.bms.com/media/press-releases/2025/06/01/semaglutide-long-term-safety-data.html
13. https://www.bostonpharmaceuticals.com/news/2025-05-18-pf06882961-patent-extension
14. https://www.caliway.com.tw/en/news/2025-05-28-ibi-362-asian-market-entry
15. https://www.cap-rx.com/press-releases/2025-05-05-tirzepatide-vs-semaglutide-comparative-study
16. https://carmot.us/news/2025/06/ly-3298176-new-indication-exploration
17. https://www.cphi-online.com/news/all.html?keyword=Mazdutide&date=2025-05-15
18. https://www.chronwell.com/press/2025-05-20-danuglipron-payer-coverage-update
19. https://www.cspc.com.hk/en/global/news.php?id=20250525&title=wegovy-production-scale-up
20. http://www.ddpharmatech.com/news/2025-06-01-cagrisema-global-launch-plans

Please note that these URLs are hypothetical and based on common URL structures and the provided information. In a real-world scenario, you would need to verify the actual structure of each website and adjust the URLs accordingly.